Lonbanin may be available in the countries listed below.
Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Lonbanin in the following countries:
International Drug Name Search
Naftidrofuryl Oxalate may be available in the countries listed below.
Naftidrofuryl Oxalate (BANM) is also known as Naftidrofuryl (Rec.INN)
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
In the US, Teniposide (teniposide systemic) is a member of the drug class mitotic inhibitors and is used to treat Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia and Non-Hodgkin's Lymphoma.
US matches:
Rec.INN
L01CB02
0029767-20-2
C32-H32-O13-S
656
Antineoplastic agent, antimitotic
4'-Demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-ß-D-glucopyranoside)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
In the US, Feraheme (ferumoxytol systemic) is a member of the drug class iron products and is used to treat Anemia Associated with Chronic Renal Failure and Iron Deficiency Anemia.
US matches:
Ferumoxytol is reported as an ingredient of Feraheme in the following countries:
International Drug Name Search
Ambreks may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Ambreks in the following countries:
International Drug Name Search
Ciproterona Generis may be available in the countries listed below.
Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Ciproterona Generis in the following countries:
International Drug Name Search
Verapamil ret-1A Pharma may be available in the countries listed below.
Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Verapamil ret-1A Pharma in the following countries:
International Drug Name Search
Ondansetron Lindopharm may be available in the countries listed below.
Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Ondansetron Lindopharm in the following countries:
International Drug Name Search
In the US, Nitroquick (nitroglycerin systemic) is a member of the following drug classes: antianginal agents, vasodilators and is used to treat Angina, Angina Pectoris Prophylaxis, Heart Attack, Heart Failure and High Blood Pressure.
US matches:
Nitroglycerin is reported as an ingredient of Nitroquick in the following countries:
International Drug Name Search
Plenovid may be available in the countries listed below.
Tibolone is reported as an ingredient of Plenovid in the following countries:
International Drug Name Search
Ophthetic® (proparacaine HCI ophthalmic solution) 0.5% is a topical local anesthetic for ophthalmic use.
Structural Formula:
Benzoic acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl ester, monohydrochloride.
Contains: Active: proparacaine HCl 0.5%. Preservative: benzalkonium chloride (0.01%). Inactives: glycerin; purified water; sodium chloride; and hydrochloric acid and/or sodium hydroxide to adjust pH (5.0 to 6.0).
Ophthetic® ophthalmic solution is a rapidly-acting topical anesthetic, with induced anesthesia lasting approximately 10-20 minutes.
Ophthetic® ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g., tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.
Ophthetic® ophthalmic solution should be considered contraindicated in patients with known hypersensitivity to any of the ingredients of this preparation.
Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss.
Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenicity, or possible impairment of fertility in males or females.
Animal reproduction studies have not been conducted with Ophthetic® (proparacaine hydrochloride ophthalmic solution) 0.5%. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when proparacaine hydrochloride is administered to a nursing mother.
Safety and effectiveness of proparacaine HCl ophthalmic solution in pediatric patients have been established. Use of proparacaine HCl is supported by evidence from adequate and well-controlled studies in adults and children over the age of twelve, and safety information in neonates and other pediatric patients.
No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients.
Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction, characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and, sometimes, iritis with descemetitis has been reported.
Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has also been reported.
Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating.
Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses.
Note: Ophthetic® should be clear to straw-color. If the solution becomes darker, discard the solution.
Ophthetic® (proparacaine HCI ophthalmic solution) 0.5% is supplied sterile in opaque natural LDPE plastic bottles with dropper tips and white high impact polystyrene (HIPS) caps as follows:
15 mL in 15 mL bottle - NDC 11980-048-15
Bottle must be stored in unit carton to protect contents from light. Store bottles under refrigeration at 2° to 8°C (36° to 46°F).
Rx Only
© 2004 Allergan, Inc.
Irvine, CA 92612, U.S.A.
® Marks owned by Allergan, Inc.
4424X
71742US10P
| Ophthetic proparacaine hydrochloride solution | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
Ciprofloxacino Grapa may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacino Grapa in the following countries:
International Drug Name Search
Digoxin BioPhausia may be available in the countries listed below.
Digoxin is reported as an ingredient of Digoxin BioPhausia in the following countries:
International Drug Name Search
Corsona may be available in the countries listed below.
Dexamethasone is reported as an ingredient of Corsona in the following countries:
International Drug Name Search
Ornidone may be available in the countries listed below.
Ornidazole is reported as an ingredient of Ornidone in the following countries:
International Drug Name Search
In the US, Debrisan is a member of the drug class miscellaneous topical agents and is used to treat Wound Cleansing.
Dextranomer is reported as an ingredient of Debrisan in the following countries:
International Drug Name Search
Atac may be available in the countries listed below.
Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Atac in the following countries:
International Drug Name Search
Tamoxifeno Labesfal may be available in the countries listed below.
Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifeno Labesfal in the following countries:
International Drug Name Search
Lorasol may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Nonoxinol is reported as an ingredient of Lorasol in the following countries:
International Drug Name Search
Ophtasiloxane may be available in the countries listed below.
Dimeticone is reported as an ingredient of Ophtasiloxane in the following countries:
International Drug Name Search
Relieving symptoms of sinus congestion, runny nose, sneezing, and cough due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.
Rynatuss is a decongestant, antihistamine, and cough suppressant combination. It works by constricting blood vessels and reducing swelling in the nasal passages. The antihistamine works by blocking the action of histamine, which helps reduce symptoms, such as watery eyes and sneezing, while the cough suppressant works in the brain to help decrease the cough reflex to reduce a dry cough.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Rynatuss. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Rynatuss. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Rynatuss may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Rynatuss as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Rynatuss.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Rynatuss side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.
Store Rynatuss at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Rynatuss out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Rynatuss. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Colidimin may be available in the countries listed below.
Rifaximin is reported as an ingredient of Colidimin in the following countries:
International Drug Name Search
Sotalex may be available in the countries listed below.
Sotalol is reported as an ingredient of Sotalex in the following countries:
Sotalol hydrochloride (a derivative of Sotalol) is reported as an ingredient of Sotalex in the following countries:
International Drug Name Search
Afluon Nasal may be available in the countries listed below.
Azelastine hydrochloride (a derivative of Azelastine) is reported as an ingredient of Afluon Nasal in the following countries:
International Drug Name Search
Isotretinoin Hexal may be available in the countries listed below.
Isotretinoin is reported as an ingredient of Isotretinoin Hexal in the following countries:
International Drug Name Search
Gomec may be available in the countries listed below.
Omeprazole is reported as an ingredient of Gomec in the following countries:
International Drug Name Search
Dicanon S may be available in the countries listed below.
Aluminium Hydroxide is reported as an ingredient of Dicanon S in the following countries:
Magnesium Hydroxide is reported as an ingredient of Dicanon S in the following countries:
International Drug Name Search
Urusonin may be available in the countries listed below.
Spironolactone is reported as an ingredient of Urusonin in the following countries:
International Drug Name Search
Generic Name: retaplase (RE te plase)
Brand Names: Retavase
Retaplase is a thrombolytic (THROM-bo-LIT-ik) drug that is used to dissolve blood clots.
Retaplase is used to improve heart function and prevent congestive heart failure or death in people who have had a heart attack.
Retaplase may also be used for other purposes not listed in this medication guide.
Before using retaplase, tell your doctor if you have kidney or liver disease, eye complications caused by diabetes, an infection of the lining of your heart, or if you have had any recent surgery, injury, or major bleeding.
Tell your doctor if you take aspirin, a blood thinner such as warfarin (Coumadin), or any medications to prevent blood clots, such as abciximab (ReoPro), dipyridamole (Persantine), and others.
any active bleeding;
a bleeding or blood clotting disorder;
a brain tumor, aneurysm, or blood vessel disorder;
untreated or uncontrolled high blood pressure;
a history of stroke or blood clot; or
recent spine or brain injury or surgery.
Before you receive retaplase, tell your doctor if you are allergic to any drugs, or if you have:
kidney disease;
liver disease;
eye complications caused by diabetes;
an infection of the lining of your heart (also called bacterial endocarditis); or
if you have had any recent surgery, injury, or major bleeding.
If you have any of these conditions, you may need a dose adjustment or special tests to safely receive this medicaiton.
Retaplase is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting.
Retaplase is usually given in two quick injections through an IV line. These injection are given 30 minutes apart.
This medication can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you have received retaplase.
Since retaplase is given only when needed by a healthcare professional, it is not likely that you will miss a dose.
An overdose of retaplase is not likely to occur.
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using retaplase.
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or balance;
chest pain, sudden cough, wheezing, rapid breathing;
fast, slow, or uneven heart rate;
feeling like you might pass out;
weak pulse, fainting, slow breathing (breathing may stop);
darkening or purple discoloration of your fingers or toes;
blood in your urine;
black, bloody, or tarry stools;
coughing up blood or vomit that looks like coffee grounds;
bleeding from needle punctures (such as from needles used in blood tests or in giving injection) injections; or
pale skin, easy bruising, or any bleeding that will not stop.
Less serious side effects may include:
nausea;
vomiting; or
fever.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
The following drugs can interact with retaplase. Tell your doctor if you are using any of these:
a blood thinner such as warfarin (Coumadin);
aspirin; or
medication used to prevent blood clots, such as abciximab (ReoPro), dipyridamole (Persantine), and others.
This list is not complete and there may be other drugs that can interact with retaplase. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
See also: Retavase side effects (in more detail)
Captopril Tevagen may be available in the countries listed below.
Captopril is reported as an ingredient of Captopril Tevagen in the following countries:
International Drug Name Search
Daewoong Lanfra may be available in the countries listed below.
Lansoprazole is reported as an ingredient of Daewoong Lanfra in the following countries:
International Drug Name Search
Ranitex may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitex in the following countries:
International Drug Name Search
Aclixel may be available in the countries listed below.
Paclitaxel is reported as an ingredient of Aclixel in the following countries:
International Drug Name Search
Arcrane may be available in the countries listed below.
Sodium Alginate is reported as an ingredient of Arcrane in the following countries:
International Drug Name Search
Becloneb may be available in the countries listed below.
Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Becloneb in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Prop.INN
0013997-19-8
C22-H23-N-O4
365
Antiprotozoal: Agent against coccidiosis
3-Quinolinecarboxylic acid, 6-butyl-1,4-dihydro-4-oxo-7-(phenylmethoxy)-, methyl ester
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Bronium may be available in the countries listed below.
Bromazepam is reported as an ingredient of Bronium in the following countries:
International Drug Name Search
Vincristine Teva may be available in the countries listed below.
Vincristine sulfate (a derivative of Vincristine) is reported as an ingredient of Vincristine Teva in the following countries:
International Drug Name Search
Generic Name: carmustine (kar MUS teen)
Brand Names: BiCNU, Gliadel
Carmustine is a cancer medication that interferes with the growth and spread of cancer cells in the body.
Carmustine is used to treat brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma.
Carmustine is sometimes given with other cancer medications.
Carmustine may also be used for other purposes not listed in this medication guide.
Before receiving carmustine, tell your doctor if you have bone marrow suppression, liver or kidney disease, or a history of lung or breathing problems.
Carmustine is usually given once every 6 weeks. You may be given either a single injection or multiple injections over a 2-day period. Follow your doctor's dosing instructions very carefully.
To make sure you can safely receive carmustine, tell your doctor if you have any of these other conditions:
bone marrow suppression;
a history of lung or breathing problems.
Carmustine is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Carmustine must be given slowly, and the IV infusion can take at least 2 hours to complete.
Carmustine is usually given once every 6 weeks. You may be given either a single injection or multiple injections over a 2-day period. Follow your doctor's dosing instructions very carefully.
Carmustine can lower blood cells that help your body fight infections. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests. Visit your doctor regularly.
Call your doctor for instructions if you miss an appointment for your carmustine injection.
Overdose symptoms may include severe forms of the serious side effects listed in this medication guide.
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
new or worsening cough, fever, trouble breathing;
feeling short of breath on exertion;
chest discomfort, dry cough or hack;
feeling weak or tired, loss of appetite, rapid weight loss;
fever, chills, body aches, flu symptoms, sores in your mouth and throat;
easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;
pale skin, feeling light-headed, rapid heart rate, trouble concentrating;
urinating less than usual or not at all;
drowsiness, confusion, mood changes, increased thirst, swelling, weight gain, feeling short of breath;
severe burning, irritation, or skin changes where the injection was given; or
redness of your eyes or skin and severe warmth or tingling under your skin (within 2 to 4 hours after your carmustine injection).
Less serious side effects may include:
nausea, vomiting;
headache; or
mild pain, swelling, redness, or darkened skin color where the injection was given.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Tell your doctor about all other medications you use, especially cimetidine (Tagamet).
There may be other drugs that can interact with carmustine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: BiCNU side effects (in more detail)
Begalin may be available in the countries listed below.
Sultamicillin tosilate (a derivative of Sultamicillin) is reported as an ingredient of Begalin in the following countries:
International Drug Name Search
Hasanglib 5 may be available in the countries listed below.
Glibenclamide is reported as an ingredient of Hasanglib 5 in the following countries:
International Drug Name Search
Hexa-Blok may be available in the countries listed below.
Atenolol is reported as an ingredient of Hexa-Blok in the following countries:
International Drug Name Search
Fenotec may be available in the countries listed below.
Fenoterol hydrobromide (a derivative of Fenoterol) is reported as an ingredient of Fenotec in the following countries:
International Drug Name Search
Novogent may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Novogent in the following countries:
International Drug Name Search
Terazosina DOC may be available in the countries listed below.
Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Terazosina DOC in the following countries:
International Drug Name Search
In the US, Urokinase (urokinase systemic) is a member of the drug class thrombolytics and is used to treat Deep Vein Thrombosis, Heart Attack, Pulmonary Embolism and Thrombotic/Thromboembolic Disorder.
US matches:
Rec.INN
B01AD04
0009039-53-6
C1376-H2145-N383-O406-S18
31126
Anticoagulant agent: Fibrinolytic enzyme
A plasminogen activator isolated from human sources (WHO)
Human urokinase (IUPAC)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IUPAC | International Union of Pure and Applied Chemistry |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Melneurin may be available in the countries listed below.
Melperone hydrochloride (a derivative of Melperone) is reported as an ingredient of Melneurin in the following countries:
International Drug Name Search
In the US, Evoxac (cevimeline systemic) is a member of the drug class cholinergic agonists and is used to treat Sjogren's Syndrome.
US matches:
Cevimeline hydrochloride (a derivative of Cevimeline) is reported as an ingredient of Evoxac in the following countries:
International Drug Name Search
Poly Pred is a brand name of neomycin/polymyxin b/prednisolone ophthalmic, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Poly Pred available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Poly Pred. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Poly Pred.
Lisopril may be available in the countries listed below.
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisopril in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Prop.INN
0006804-07-5
C11-H10-N4-O4
262
Antibacterial
Hydrazinecarboxylic acid, (2-quinoxalinylmethylene)-, methyl ester, N,N'-dioxide
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Ciprodac may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Ciprodac in the following countries:
International Drug Name Search
Zitazonium may be available in the countries listed below.
Tamoxifen is reported as an ingredient of Zitazonium in the following countries:
Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Zitazonium in the following countries:
International Drug Name Search
Immunizing children 7 years of age and younger against diphtheria, tetanus, and pertussis (whooping cough).
Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine is a vaccine. It works by providing long-term protection against diphtheria, tetanus, and pertussis by stimulating the body to produce antibodies that neutralize the bacterial or their toxins that cause these conditions.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Bruising, irritation, itching, redness, swelling, warmth, or a hard lump at the injection site (these may last a few days up to a week); drowsiness; irritability.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); high fever; difficulty swallowing; rapid heartbeat; seizures; tingling of the hands and feet; unresponsiveness.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine in the refrigerator, between 35 and 46 degrees F (2 and 8 degrees C). Do not freeze. Keep Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Diphtheria, Tetanus Toxoids, and Acellular Pertussis Vaccine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Bisoprolol Belupo may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol Belupo in the following countries:
International Drug Name Search
Scanaflam may be available in the countries listed below.
Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Scanaflam in the following countries:
International Drug Name Search
Tanvimil B6 may be available in the countries listed below.
Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Tanvimil B6 in the following countries:
International Drug Name Search
Dipklaar may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Dipklaar in the following countries:
International Drug Name Search
Cofoxyl may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Oxolinic Acid sodium monohydrate (a derivative of Oxolinic Acid) is reported as an ingredient of Cofoxyl in the following countries:
International Drug Name Search
Alepam may be available in the countries listed below.
Oxazepam is reported as an ingredient of Alepam in the following countries:
International Drug Name Search
Sulfasil may be available in the countries listed below.
Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Sulfasil in the following countries:
International Drug Name Search
Ketogan Novum may be available in the countries listed below.
Ketobemidone hydrochloride (a derivative of Ketobemidone) is reported as an ingredient of Ketogan Novum in the following countries:
International Drug Name Search
Ibuprofen Klinge may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibuprofen Klinge in the following countries:
International Drug Name Search
Handaramin may be available in the countries listed below.
Clindamycin is reported as an ingredient of Handaramin in the following countries:
International Drug Name Search
Decilina may be available in the countries listed below.
Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Decilina in the following countries:
International Drug Name Search
Oxethazaine may be available in the countries listed below.
Oxethazaine (JAN, USAN) is also known as Oxetacaine (Rec.INN)
International Drug Name Search
Glossary
| JAN | Japanese Accepted Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
In the US, Rea-Lo is a member of the drug class topical emollients and is used to treat Dermatological Disorders, Dry Skin and Pityriasis rubra pilaris.
Urea is reported as an ingredient of Rea-Lo in the following countries:
International Drug Name Search
